BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Diagnosis
200 results:

  • 1. Development and Validation of Case-Finding Algorithms to Identify pancreatic cancer in the Veterans Health Administration.
    Mezzacappa C; Larki NR; Skanderson M; Park LS; Brandt C; Hauser RG; Justice A; Yang YX; Wang L
    Dig Dis Sci; 2024 Apr; 69(4):1507-1513. PubMed ID: 38453743
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy of endoscopic ultrasound-guided tissue acquisition using stereo-microscopic on-site evaluation for possible comprehensive genome profile in patients with advanced pancreatic cancer.
    Okuwaki K; Watanabe M; Yoshida T; Tamaki A; Iwai T; Adachi K; Ishizaki J; Hanaoka T; Imaizumi H; Kida M; Kusano C
    J Gastroenterol Hepatol; 2024 Apr; 39(4):740-745. PubMed ID: 38229203
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
    Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
    Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
    Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nationwide Use and Outcome of Surgery for Locally Advanced pancreatic cancer Following Induction Chemotherapy.
    Stoop TF; Seelen LWF; van 't Land FR; Lutchman KRD; van Dieren S; Lips DJ; van der Harst E; Kazemier G; Patijn GA; de Hingh IH; Wijsman JH; Erdmann JI; Festen S; Groot Koerkamp B; Mieog JSD; den Dulk M; Stommel MWJ; Busch OR; de Wilde RF; de Meijer VE; Te Riele W; Molenaar IQ; van Eijck CHJ; van Santvoort HC; Besselink MG;
    Ann Surg Oncol; 2024 Apr; 31(4):2640-2653. PubMed ID: 38105377
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.met. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey.
    Libia A; Podda M; Di Martino M; Pata F; Pellino G; Di Saverio S; Anselmo A; Muttillo EM; De Pastena M; Campanile FC; Ielpo B; Spampinato MG;
    Updates Surg; 2024 Jan; 76(1):43-55. PubMed ID: 37875725
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical and genomic characterisation of early-onset pancreatic cancer.
    Castet F; Fabregat-Franco C; Castillo G; Navarro V; Sierra A; Acosta DA; López-Valbuena D; Dienstmann R; Tabernero J; Vivancos A; Tian TV; Macarulla T
    Eur J Cancer; 2023 Nov; 194():113338. PubMed ID: 37793216
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial.
    Corti F; Brizzi MP; Amoroso V; Giuffrida D; Panzuto F; Campana D; Prinzi N; Milione M; Cascella T; Spreafico C; Randon G; Oldani S; Leporati R; Scotto G; Pulice I; Stocchetti BL; Porcu L; Coppa J; Di Bartolomeo M; de Braud F; Pusceddu S
    BMC Cancer; 2023 Sep; 23(1):908. PubMed ID: 37752423
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of the Quality and Comprehensiveness of YouTube Videos Discussing pancreatic cancer.
    Didier AJ; Fang L; Stiene J; Spencer CT; Hamouda DM
    J Cancer Educ; 2023 Dec; 38(6):1894-1900. PubMed ID: 37606727
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (CEA) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles.
    Kiio LK; Onyatta JO; Ndangili PM; Oloo F; Santamaria C; Montuenga LM; Mbui DN
    Talanta; 2024 Jan; 266(Pt 1):124934. PubMed ID: 37454512
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
    Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
    Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced pancreatic cancer.
    Parikh PJ; Lee P; Low DA; Kim J; Mittauer KE; Bassetti MF; Glide-Hurst CK; Raldow AC; Yang Y; Portelance L; Padgett KR; Zaki B; Zhang R; Kim H; Henke LE; Price AT; Mancias JD; Williams CL; Ng J; Pennell R; Pfeffer MR; Levin D; Mueller AC; Mooney KE; Kelly P; Shah AP; Boldrini L; Placidi L; Fuss M; Chuong MD
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):799-808. PubMed ID: 37210048
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma.
    Kong Y; Xie F; Zhang Z; Wang S; Zhang Y; Di Y; Zhou Z; Jiang D; Li J; Huang Q; Wang J; Li X; Pan Z; Ni R; Guan Y
    Eur Radiol; 2023 Oct; 33(10):7077-7088. PubMed ID: 37166496
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment.
    Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W
    Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. An analysis of time to treatment in patients with pancreatic adenocarcinoma.
    Sugumar K; Gendi S; Quereshy HA; Gupta S; Hue JJ; Rothermel LD; Ocuin LM; Ammori JB; Hardacre JM; Winter JM
    Surgery; 2023 Jul; 174(1):83-90. PubMed ID: 37105784
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings.
    Malcolm JA; Tacey M; Gibbs P; Lee B; Ko HS
    Eur Radiol; 2023 Oct; 33(10):6659-6669. PubMed ID: 37079029
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Adherence to NCCN Genetic Testing Guidelines in pancreatic cancer and Impact on Treatment.
    Crowley F; Gandhi S; Rudshteyn M; Sehmbhi M; Cohen DJ
    Oncologist; 2023 Jun; 28(6):486-493. PubMed ID: 36933202
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer.
    Dhamane AD; Shah S; Noxon V; Bruette R; Ferri M; Liu X; Jiang J; Luo X
    Thromb Res; 2023 Apr; 224():52-59. PubMed ID: 36848784
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Outcomes after Frey's procedure for chronic pancreatitis: a 8-year single-center experience in Colombia.
    González J; Ayala D; Caballero N; Rey Chaves CE; Conde D; Sabogal Olarte JC
    BMC Surg; 2022 Dec; 22(1):424. PubMed ID: 36503674
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.